Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human ...
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections ...
According to Vision Research Reports, the U.S. in vitro diagnostics market size was estimated at USD 29.88 billion in 2023 and it is expected to surpass around USD 43.05 billion by 2033 According to ...